Živná H. 1, Živný P. 2, Feřtek D. 2, Hrubá P. 2, Palička V. 2:
Differences of Fat Tissue Metabolism
between Normocholesterolemic and Hypercholesterolemic Rats
|
4 |
Hrubá P.1, Živný P.1, Živná H.2, Palička V.1:
Muscle, Liver and Kidney Interstitium Blood
Flow Changes in Rats Measured by Microdialysis with Flow-marker Added
|
9 |
Rejchrt S.1, Bureš J.1, Plíšková L.2, Živný P.2, Široký M.1, Kopáčová M.1, Palička V.2:
Topical
Duodenal and Gastric Mucosal Production of Interleukin-1 beta, Interleukin-6, Interleukin-
8, Tumour Necrosis alpha and Interleukin-2-soluble Receptor in Helicobacter
pylori Positive and Negative Patients
|
14 |
Rejchrt S.1, Havlasová J.2, Bureš J.1, Široký M.1, Kopáčová M.1, Voxová B.3, Krejsek J.2:
Evaluation of Serum anti-Helicobacter Pylori IgG Antibodies against p120 Antigen
(CagA) and Investigation of Specific Antibody Response against Helicobacter pylori by
Means of Western Blotting
|
19 |
Bezděk V.:
Computation of Michaelis Constant KM Using “a Step by Step“ Method
|
27 |
Krajčovičová-Kudláčková M., Valachovičová M., Pauková:
Plasma Protein Carbonyls in Relation to
Antioxidative Status
|
35 |
Stárka L.:
19-nortestosterone and anti-doping Control
|
38 |
Slabík D.1, 4, Freiberger T.2, Tomašovičová Z.3, Kamarýt J.4:
Macrocomplex of Aspartate
Aminotransferase as a Cause of Unexplained Hyperactivity of Aspartate Aminotransferase
|
42 |
Dastych M., Malášková L., Peprla J., Klimeš K.:
Quality Management System in Clinical
Biochemistry according to Standard ISO 9001:2000
|
46 |
Maruna P., Vokurka M., Krijt J.:
Hepcidin – a New Peptide of Inflammatory Response
and Iron Metabolism
|
55 |
Friedecký B., Plíšková L., Hrochová K., Palička V.:
Some Recent DNA /RNA Analysis
Interlaboratory Comparison Programme
|
60 |
